Mandate

Vinge advises AB Novestra in connection with its in kind acquisition of Strax Group GmbH and change of name to Strax AB

May 19, 2016

Vinge has advised AB Novestra (publ) (“Novestra”) in connection with its acquisition of Strax Group GmbH. The acquisition was approved by the annual general meeting of shareholders in Novestra on April 26, 2016 and the general meeting also resolved to change the name of the company to Strax AB. The acquisition of the shares in Strax Group GmbH was made by an issue in kind where the purchase price consisted of 80 571 293 newly issued shares in Novestra. The newly issued shares were admitted to trading on Nasdaq Stockholm, Small Cap, on May 12, 2016 under the new ticker STRAX.

Strax is a global specialist within mobile accessories with own brands, such as Xqisit, Gear4, Urbanista, Agna and Avo. The own brands are complemented with OEM brands, aftermarket brands, licensed brands and an end-to-end service offering. In total, Strax has in excess of 600 B2B customers worldwide, including customers such as Dixons Carphone, Staples, Swisscom, Telenor, T-Mobile and Amazon. Strax operates through subsidiaries in Germany, France, UK, Sweden, Norway, Denmark, the Netherlands, Switzerland, Poland, the US, Hong Kong and China.

Vinge’s team primarily consisted of Jesper Schönbeck, Rikard Lindahl, Matthias Pannier and Malte Hedlund.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025